RPS3AP28

Across TCGA pan-cancer cohorts, RPS3AP28 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RPS3AP28 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RPS3AP28 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPS3AP28 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LAML show a favorable association.

LUAD, STAD, and LAML are the cancer types where RPS3AP28 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.457	0.282	<.001	70	view →
STAD	DFS	Tertile	All	0.287	0.517	.001	65	view →
LAML	DFS	Median	All	0.611	0.306	<.001	48	view →
CHOL	OS	Tertile	III,IV	0.136	0.859	.003	27	view →
BRCA	DFS	Tertile	IV	1.000	0.610	.011	18	view →
LIHC	DFS	Tertile	III,IV	0.110	0.447	.001	18	view →
GBM	OS	Tertile	All	0.347	0.213	.005	15	view →
UCS	OS	Tertile	IV	1.000	0.260	.024	12	view →
PAAD	DFS	Tertile	All	0.345	0.488	.044	9	view →
READ	DFS	Tertile	IV	0.514	0.636	.008	9	view →
COAD	OS	Tertile	IV	1.000	0.531	.035	9	view →
ESCA	OS	Quartile	III,IV	0.747	0.326	.009	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RPS3AP28–LUAD (DFS)

Open the LUAD breakdown →